Home
About Opexa
About Opexa
Management Team
Board of Directors
Scientific Advisory Board
Facility
Contact Us
Tcelna®
Tcelna® Description
TERMS Phase 2b Overview
MS Overview
Publications
Clinical Trials
Abili-T Clinical Study Overview
ImmForm® Clinical Management Tool
Technology
T-cell Platform
Stem Cell Platform
Opexa cGMP Manufacturing
News & Resources
Multimedia
Press Releases
Webcasts
Publications
Conference & Meeting Presentations
Investor Relations
Why Invest
Press Releases
Events & Presentations
Stock Information
SEC Filings
Financial Reports
Corporate Governance
Corporate Factsheet
Investor FAQs
Careers
Working at Opexa
Open Positions
How to Apply
Living in The Woodlands
Contact Us
Precision Immunotherapy™
Home
/
Investor Relations
/
Events & Presentations
/
Event Details
Investor Relations
Why Invest
Press Releases
Events & Presentations
Stock Information
SEC Filings
Financial Reports
Corporate Governance
Corporate Factsheet
Investor FAQs
Why Invest
Press Releases
Events & Presentations
Stock Information
SEC Filings
Financial Reports
Corporate Governance
Corporate Factsheet
Investor FAQs
Quick Links
Factsheet
Financial Reports
FAQs
Contact IR
About Opexa
Tcelna®
Clinical Trials
Contact Us
Email Alerts
Email Address
*
Mailing Lists
*
Releases
SEC Filings
Presentation
Events
Unsubscribe from email alerts
The 9th Annual Burrill Personalized Medicine Meeting
from September 30, 2022 to October 1, 2021
Time: 09:00 AM EST
Neil K. Warma, President & CEO - invited panelist
San Francisco, CA
View the live Webcast
View the Press Release
(
)
View the Related Document
(
)
© 2013 Opexa Therapeutics, Inc. All Rights Reserved.
Privacy Policy
Terms of Use
Powered By Q4 Web Systems
3.8.2.5467